Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects

被引：0
|
作者：
Sybil Skinner-Robertson
Caroline Fradette
Sylvie Bouchard
Mohamad-Samer Mouksassi
France Varin
机构：
[1] Université de Montréal,Faculté de pharmacie
[2] Labopharm Inc,undefined
[3] Lakeshore General Hospital,undefined
[4] Certara Consulting Services,undefined
来源：
Drugs & Aging | 2015年 / 32卷
关键词：
Tramadol; Elderly Subject; Young Subject; Food Effect; Objective Function Value;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1029 / 1043
页数：14
相关论文
共 50 条
  • [21] Extended-release niacin pharmacokinetics following multiple-dose administration.
    Cefali, EA
    Adams, MH
    PHARMACOTHERAPY, 2003, 23 (03): : 410 - 410
  • [22] Variability in the pharmacokinetics of acetaminophen following multiple dose administration of MNK-795 (oxycodone and acetaminophen extended-release tablets) is affected by covariates
    Morton, T.
    Franke, R.
    Devarakonda, K.
    JOURNAL OF PAIN, 2014, 15 (04): : S80 - S80
  • [23] COMPARATIVE PHARMACOKINETICS OF EXTENDED-RELEASE VERSUS CONVENTIONAL TRAMADOL/ACETAMINOPHEN FIXED-DOSE COMBINATION TABLETS IN HEALTHY VOLUNTEERS.
    Yi, S. J.
    Kim, T. E.
    Jeon, H. W.
    Shin, H. S.
    Yoon, S. H.
    Cho, J. Y.
    Yu, K. S.
    Jang, I. J.
    Shin, S. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S87 - S88
  • [24] Pharmacokinetics, metabolism, and saliva output during transidermal and extended-release oral oxybutynin administration in healthy subjects
    Appell, RA
    Chancellor, MB
    Zobrist, RH
    Thomas, H
    Sanders, SW
    MAYO CLINIC PROCEEDINGS, 2003, 78 (06) : 696 - 702
  • [25] Levodopa pharmacokinetics following administration of novel gastric retentive extended-release formulations compared to a reference extended-release tablet in Parkinson's disease patients
    Stolyarov, I. D.
    Illarioshkin, S. N.
    Chen, C.
    Hou, S. Y. E.
    Cowles, V. E.
    Sweeney, M.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S144 - S144
  • [26] Influence of CYP2D6 inhibition on pharmacokinetics of tramadol HCl extended release tablets in normal healthy subjects
    Lai, John Chi-Keung
    Sista, Suryanarayana
    Eradiri, Okponanabofa
    Danyluk, Alexander
    Brett, Vincent
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1092 - 1092
  • [27] Pharmacokinetics of Trans-resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects
    Nunes, Teresa
    Almeida, Luis
    Rocha, Jose-Francisco
    Falcao, Amilcar
    Fernandes-Lopes, Carlos
    Loureiro, Ana I.
    Wright, Lyndon
    Vaz-da-Silva, M.
    Soares-da-Silva, Patricio
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (12): : 1477 - 1482
  • [28] Comparative Pharmacokinetics of a Once-Daily Tramadol Extended-Release Tablet and an Immediate-Release Reference Product Following Single-Dose and Multiple-Dose Administration
    Karhu, David
    Fradette, Caroline
    Potgieter, Maria Alida
    Ferreira, Maria M.
    Terblanche, Johann
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (05): : 544 - 553
  • [29] Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration
    Brenda Cirincione
    Jeffrey Edwards
    Donald E. Mager
    The AAPS Journal, 2017, 19 : 487 - 496
  • [30] Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration
    Cirincione, Brenda
    Edwards, Jeffrey
    Mager, Donald E.
    AAPS JOURNAL, 2017, 19 (02): : 487 - 496
12345